The landscape of dementia prognosis has advanced radically with the appearance of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years before symptoms arise. Even though these technological developments signify remarkable development in knowing neurodegenerative illnesses, they have not diminished https://francisl135nom7.elbloglibre.com/profile